{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T16:24:59Z","timestamp":1793982299258,"version":"4.8.0"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,4,5]],"date-time":"2019-04-05T00:00:00Z","timestamp":1554422400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100004440","name":"Wellcome Trust","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004440","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Med"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1186\/s12916-019-1310-0","type":"journal-article","created":{"date-parts":[[2019,4,5]],"date-time":"2019-04-05T01:02:44Z","timestamp":1554426164000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":32,"title":["Predicting COPD 1-year mortality using prognostic predictors routinely measured in primary care"],"prefix":"10.1186","volume":"17","author":[{"given":"C. I.","family":"Bloom","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Ricciardi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Smeeth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Stone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. K.","family":"Quint","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,4,5]]},"reference":[{"key":"1310_CR1","doi-asserted-by":"publisher","first-page":"A20.1","DOI":"10.1136\/thoraxjnl-2016-209333.38","volume":"71","author":"N Snell","year":"2016","unstructured":"Snell N, et al. S32 epidemiology of chronic obstructive pulmonary disease (COPD) in the UK: findings from the British lung foundation\u2019s \u2018respiratory health of the nation\u2019 project. Thorax. 2016;71:A20.1\u2013A20.","journal-title":"Thorax"},{"key":"1310_CR2","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1016\/S2213-2600(17)30293-X","volume":"5","author":"GBD 2015 Chronic Respiratory Disease Collaborators, J. B","year":"2017","unstructured":"GBD 2015 Chronic Respiratory Disease Collaborators, J. B, et al. Global, regional, and national deaths, prevalence, disability-adjusted life years, and years lived with disability for chronic obstructive pulmonary disease and asthma, 1990-2015: a systematic analysis for the Global Burden of Disease Study 2015. Lancet Respir Med. 2017;5:691\u2013706.","journal-title":"Lancet Respir Med"},{"key":"1310_CR3","unstructured":"National Institute for Health and Care Excellence (NICE). Chronic Obstructive Pulmonary Disease in over 16s: diagnosis and managment (NICE Guideline). 2018."},{"key":"1310_CR4","doi-asserted-by":"publisher","first-page":"988","DOI":"10.1016\/S0140-6736(17)32127-X","volume":"390","author":"M Maddocks","year":"2017","unstructured":"Maddocks M, Lovell N, Booth S, Man WD-C, Higginson IJ. Palliative care and management of troublesome symptoms for people with chronic obstructive pulmonary disease. Lancet. 2017;390:988\u20131002.","journal-title":"Lancet"},{"key":"1310_CR5","volume-title":"Commissioning End of Life Care","author":"National Council for Palliative Care","year":"2011","unstructured":"National Council for Palliative Care. Commissioning End of Life Care. (2011)."},{"key":"1310_CR6","doi-asserted-by":"publisher","unstructured":"Gershon AS, et al. End of life strategies among patients with advanced chronic obstructive pulmonary disease (COPD). AJRCCM Artic Press. 2018:03\u2013592. \n                    https:\/\/doi.org\/10.1164\/rccm.201803-0592OC\n                    \n                  .","DOI":"10.1164\/rccm.201803-0592OC"},{"key":"1310_CR7","doi-asserted-by":"publisher","first-page":"1701879","DOI":"10.1183\/13993003.01879-2017","volume":"51","author":"CI Bloom","year":"2018","unstructured":"Bloom CI, et al. Low uptake of palliative care for COPD patients within primary care in the UK. Eur Respir J. 2018;51:1701879.","journal-title":"Eur Respir J"},{"key":"1310_CR8","doi-asserted-by":"publisher","first-page":"2239","DOI":"10.2147\/COPD.S137868","volume":"12","author":"L-JE Smith","year":"2017","unstructured":"Smith L-JE, et al. Prognostic variables and scores identifying the end of life in COPD: a systematic review. Int J Chron Obstruct Pulmon Dis. 2017;12:2239\u201356.","journal-title":"Int J Chron Obstruct Pulmon Dis"},{"key":"1310_CR9","doi-asserted-by":"publisher","first-page":"11","DOI":"10.2147\/COPD.S698","volume":"3","author":"A Spathis","year":"2008","unstructured":"Spathis A, Booth S. End of life care in chronic obstructive pulmonary disease: in search of a good death. Int J Chron Obstruct Pulmon Dis. 2008;3:11\u201329.","journal-title":"Int J Chron Obstruct Pulmon Dis"},{"key":"1310_CR10","doi-asserted-by":"publisher","unstructured":"Halpin DM. Palliative care for COPD: signs of progress, but still a long way to go. AJRCCM Artic Press. 2018:05\u2013955. \n                    https:\/\/doi.org\/10.1164\/rccm.201805-0955ED\n                    \n                  .","DOI":"10.1164\/rccm.201805-0955ED"},{"key":"1310_CR11","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1016\/j.rmed.2018.04.003","volume":"138","author":"DR Morales","year":"2018","unstructured":"Morales DR, et al. External validation of ADO, DOSE, COTE and CODEX at predicting death in primary care patients with COPD using standard and machine learning approaches. Respir Med. 2018;138:150\u20135.","journal-title":"Respir Med"},{"key":"1310_CR12","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1136\/thx.2006.072348","volume":"62","author":"LP McGarvey","year":"2007","unstructured":"McGarvey LP, et al. Ascertainment of cause-specific mortality in COPD: operations of the TORCH Clinical Endpoint Committee. Thorax. 2007;62:411\u20135.","journal-title":"Thorax"},{"key":"1310_CR13","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1093\/ije\/dyv098","volume":"44","author":"E Herrett","year":"2015","unstructured":"Herrett E, et al. Data resource profile: clinical practice research datalink (CPRD). Int J Epidemiol. 2015;44:827\u201336.","journal-title":"Int J Epidemiol"},{"key":"1310_CR14","doi-asserted-by":"crossref","unstructured":"Quint JK, et al. Validation of chronic obstructive pulmonary disease recording in the clinical practice research datalink (CPRD-GOLD). BMJ Open. 2014;4:\u2013e005540.","DOI":"10.1136\/bmjopen-2014-005540"},{"key":"1310_CR15","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1164\/rccm.201201-0034OC","volume":"186","author":"M Divo","year":"2012","unstructured":"Divo M, et al. Comorbidities and risk of mortality in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2012;186:155\u201361.","journal-title":"Am J Respir Crit Care Med"},{"key":"1310_CR16","doi-asserted-by":"publisher","first-page":"771","DOI":"10.2147\/CLEP.S117867","volume":"8","author":"KJ Rothnie","year":"2016","unstructured":"Rothnie KJ, et al. Recording of hospitalizations for acute exacerbations of COPD in UK electronic health care records. Clin Epidemiol. 2016;8:771\u201382.","journal-title":"Clin Epidemiol"},{"key":"1310_CR17","doi-asserted-by":"publisher","first-page":"e0151357","DOI":"10.1371\/journal.pone.0151357","volume":"11","author":"KJ Rothnie","year":"2016","unstructured":"Rothnie KJ, et al. Validation of the recording of acute exacerbations of COPD in UK primary care electronic healthcare records. PLoS One. 2016;11:e0151357.","journal-title":"PLoS One"},{"key":"1310_CR18","doi-asserted-by":"publisher","first-page":"1189","DOI":"10.1164\/rccm.200902-0271OC","volume":"180","author":"RC Jones","year":"2009","unstructured":"Jones RC, et al. Derivation and validation of a composite index of severity in chronic obstructive pulmonary disease: the DOSE index. Am J Respir Crit Care Med. 2009;180:1189\u201395.","journal-title":"Am J Respir Crit Care Med"},{"key":"1310_CR19","doi-asserted-by":"publisher","first-page":"692","DOI":"10.1016\/j.rmed.2008.12.005","volume":"103","author":"JJ Soler-Catalu\u00f1a","year":"2009","unstructured":"Soler-Catalu\u00f1a JJ, Mart\u00ednez-Garc\u00eda MA, S\u00e1nchez LS, Tordera MP, S\u00e1nchez PR. Severe exacerbations and BODE index: two independent risk factors for death in male COPD patients. Respir Med. 2009;103:692\u20139.","journal-title":"Respir Med"},{"key":"1310_CR20","doi-asserted-by":"publisher","first-page":"704","DOI":"10.1016\/S0140-6736(09)61301-5","volume":"374","author":"MA Puhan","year":"2009","unstructured":"Puhan MA, et al. Expansion of the prognostic assessment of patients with chronic obstructive pulmonary disease: the updated BODE index and the ADO index. Lancet. 2009;374:704\u201311.","journal-title":"Lancet"},{"key":"1310_CR21","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1002\/(SICI)1097-0258(19990330)18:6<681::AID-SIM71>3.0.CO;2-R","volume":"18","author":"S Buuren van","year":"1999","unstructured":"van Buuren S, Boshuizen HC, Knook DL. Multiple imputation of missing blood pressure covariates in survival analysis. Stat Med. 1999;18:681\u201394.","journal-title":"Stat Med"},{"key":"1310_CR22","doi-asserted-by":"crossref","unstructured":"Rubin D. Multiple Imputation for Nonresponse in Surveys. Wiley; 1987.","DOI":"10.1002\/9780470316696"},{"key":"1310_CR23","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1002\/sim.1621","volume":"23","author":"P Royston","year":"2004","unstructured":"Royston P, Sauerbrei W. A new measure of prognostic separation in survival data. Stat Med. 2004;23:723\u201348.","journal-title":"Stat Med"},{"key":"1310_CR24","doi-asserted-by":"publisher","first-page":"2543","DOI":"10.1001\/jama.1982.03320430047030","volume":"247","author":"FE Harrell","year":"1982","unstructured":"Harrell FE, Califf RM, Pryor DB, Lee KL, Rosati RA. Evaluating the yield of medical tests. JAMA. 1982;247:2543\u20136.","journal-title":"JAMA"},{"key":"1310_CR25","doi-asserted-by":"publisher","first-page":"3401","DOI":"10.1002\/1097-0258(20001230)19:24<3401::AID-SIM554>3.0.CO;2-2","volume":"19","author":"HC Houwelingen van","year":"2000","unstructured":"van Houwelingen HC. Validation, calibration, revision and combination of prognostic survival models. Stat Med. 2000;19:3401\u201315.","journal-title":"Stat Med"},{"key":"1310_CR26","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1177\/1536867X1501500116","volume":"15","author":"P Royston","year":"2015","unstructured":"Royston P. Tools for checking calibration of a Cox model in external validation: prediction of population-averaged survival curves based on risk groups. Stata J. 2015;15:275\u201391.","journal-title":"Stata J"},{"key":"1310_CR27","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1186\/1471-2288-13-33","volume":"13","author":"P Royston","year":"2013","unstructured":"Royston P, Altman DG. External validation of a Cox prognostic model: principles and methods. BMC Med Res Methodol. 2013;13:33.","journal-title":"BMC Med Res Methodol"},{"key":"1310_CR28","doi-asserted-by":"publisher","first-page":"740","DOI":"10.1177\/0269216310375861","volume":"24","author":"N Small","year":"2010","unstructured":"Small N, et al. Using a prediction of death in the next 12 months as a prompt for referral to palliative care acts to the detriment of patients with heart failure and chronic obstructive pulmonary disease. Palliat Med. 2010;24:740\u20131.","journal-title":"Palliat Med"},{"key":"1310_CR29","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1055\/s-0035-1556063","volume":"36","author":"N Putcha","year":"2015","unstructured":"Putcha N, Drummond MB, Wise RA, Hansel NN. Comorbidities and chronic obstructive pulmonary disease: prevalence, influence on outcomes, and management. Semin Respir Crit Care Med. 2015;36:575\u201391.","journal-title":"Semin Respir Crit Care Med"},{"key":"1310_CR30","doi-asserted-by":"publisher","first-page":"375","DOI":"10.3109\/15412555.2010.510160","volume":"7","author":"CE Berry","year":"2010","unstructured":"Berry CE, Wise RA. Mortality in COPD: causes, risk factors, and prevention. COPD J Chronic Obstr Pulm Dis. 2010;7:375\u201382.","journal-title":"COPD J Chronic Obstr Pulm Dis"},{"key":"1310_CR31","doi-asserted-by":"publisher","first-page":"1945","DOI":"10.1136\/heartjnl-2016-309573","volume":"102","author":"P Bhatnagar","year":"2016","unstructured":"Bhatnagar P, Wickramasinghe K, Wilkins E, Townsend N. Trends in the epidemiology of cardiovascular disease in the UK. Heart. 2016;102:1945\u201352.","journal-title":"Heart"},{"key":"1310_CR32","doi-asserted-by":"publisher","unstructured":"Gayle A, Axson E, Bloom C, Navaratnam V, Quint J. Changing causes of death for patients with chronic respiratory disease in England, 2005-2015. Thorax. 2019. \n                    https:\/\/doi.org\/10.1136\/thoraxjnl-2018-212514\n                    \n                  .","DOI":"10.1136\/thoraxjnl-2018-212514"}],"container-title":["BMC Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12916-019-1310-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12916-019-1310-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12916-019-1310-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,4,3]],"date-time":"2020-04-03T23:07:08Z","timestamp":1585955228000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcmedicine.biomedcentral.com\/articles\/10.1186\/s12916-019-1310-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,4,5]]},"references-count":32,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["1310"],"URL":"https:\/\/doi.org\/10.1186\/s12916-019-1310-0","relation":{},"ISSN":["1741-7015"],"issn-type":[{"value":"1741-7015","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,4,5]]},"assertion":[{"value":"19 November 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 March 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 April 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The protocol for this research was approved by the Independent Scientific Advisory Committee (ISAC) for MHRA Database Research (protocol number 17_083). Generic ethical approval for observational research using CPRD with approval from ISAC has been granted by a Health Research Authority (HRA) Research Ethics Committee (East Midlands \u2013 Derby, REC reference number 05\/MRE04\/87). Linked pseudonymised data was provided for this study by CPRD. Data is linked by NHS Digital, the statutory trusted third party for linking data, using identifiable data held only by NHS Digital. Select practices consent to this process at a practice level with individual patients having the right to opt-out.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"All authors have completed the ICMJE uniform disclosure form at  and declare the following. LS reports grants from Wellcome Trust during the conduct of the study; outside the submitted work, LS reports grants from Wellcome, MRC, NIHR, BHF and Diabetes UK and grants and personal fees from GlaxoSmithKline. JKQ, outside the submitted work, reports grants from The Health Foundation, MRC, and British Lung Foundation; grants and personal fees from GlaxoSmithKline; grants and personal fees from Boehringer Ingelheim; grants and personal fees from AstraZeneca; grants and personal fees form Chiesi; personal fees from Teva; grants and personal fees from Insmed; grants and personal fees from Bayer and grants from IQVIA.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"73"}}